Neoadjuvant Cemiplimab to Facilitate Mohs Surgery tumor Extirpation and Reduce Surgical Morbidity

Authors

• Marianne Cortes, Corewell Health East Resident
• Jorge Santana
• Strassswimmer

Document Type

Conference Proceeding

Publication Date

7-2026

Publication Title

Journal of the American Academy of Dermatology

Volume

95

Issue

1 Suppl

First Page

AB311

Last Page

AB311

Recommended Citation

Cortes M, Santana J, Strasswimmer J. Neoadjuvant cemiplimab to facilitate Mohs surgery tumor extirpation and reduce surgical morbidity. J Am Acad Dermatol. 2026 Jul;95(1 Suppl):AB311. doi:10.1016/j.jaad.2026.04.1250

Comments

American Academy of Dermatology Annual Meeting, March 27-31, 2026, Denver, Co

DOI

10.1016/j.jaad.2026.04.1250